dallas semaglutide pancreatitis lawsuit glp-1 bowel obstruction in kentucky gastroparesis class action Ozempic Lawsuit: June 2026 Blindness and Gastroparesis Claims Ozempic, Wegovy & Rybelsus Lawsuit

For a full listing of all side effects linked with your weight loss drug read the product information and discuss this information with your doctor or other healthcare provider

The remarkable clinical benefits observed in our studyincluding a 55.1% reduction in mortality and substantial improvements in liver and kidney outcomeshighlight the potential of this approach to redefine MASLD management

Immunogenicity (an unwanted immune reaction) is a stated risk in FDA materials on protein-based therapeutics

10.1128/mBio.02332-18 mBio 174 TaniguchiN.IkedaY

adults: About 12% of all adults say they are currently taking a GLP-1 drug